Portfolio Holdings Detail for ISIN IE00BKVL7778
Stock Name / FundiShares Edge MSCI World Minimum Volatility ESG UCITS ETF
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300VML6THE3JJOS76
ETF TickerMVEW.DE(EUR) CXE
ETF TickerMVEW.LS(GBP) CXE
ETF TickerMVEW(USD) Euronext Amsterdam

Holdings detail for VRTX

Stock NameVertex Pharmaceuticals Inc
TickerVRTX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS92532F1003
LEI54930015RAQRRZ5ZGJ91

Show aggregate VRTX holdings

News associated with VRTX

Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Buy at StockNews.com
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Tuesday. A number of other equities analysts have also weighed in on VRTX. HC Wainwright reiterated a “buy” rating and issued a $550.00 price target on shares of […] - 2025-03-13 06:26:55
Rep. Jefferson Shreve Purchases Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Representative Jefferson Shreve (R-Indiana) recently bought shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). In a filing disclosed on March 09th, the Representative disclosed that they had bought between $15,001 and $50,000 in Vertex Pharmaceuticals stock on February 24th. The trade occurred in the Representative’s “CRT – STANDARD UNIT TRUST” account. Representative Jefferson Shreve also recently made […] - 2025-03-12 06:04:59
IVW, AXP, FI, VRTX: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares S&P 500 Growth ETF (Symbol: IVW) where we have detected an approximate $306.8 million dollar outflow -- that's a 0.6% decrease week over - 2025-03-11 15:28:55
Company News for Mar 11, 2025
Companies in The News Are: VRTX, TSLA, NVDA, COIN - 2025-03-11 13:22:00
Nasdaq Correction: The 2 Smartest Stocks to Buy and Hold Forever
When you're on an airplane, the pilot or a flight attendant will typically announce over the loudspeaker to "buckle your seatbelt" when the air is turbulent. That could be good advice for investors right now, too. - 2025-03-11 09:31:00
Where Will Vertex Pharmaceuticals Be in 10 Years?
The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its first cystic fibrosis (CF) drug -- Kalydeco -- back in 2012 and has since gained the regulatory nod for four more and become the global leader in the CF market - 2025-03-11 08:25:00
5 Top Stocks to Buy in March
2025 has gotten off to a choppy start as some of the most valuable U.S.-based companies are dragging down the major stock market indexes. But getting caught up in short-term market movements is a mistake. - 2025-03-04 11:15:00
XLV, SYK, DHR, VRTX: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $434.3 million dollar outflow -- that's a 1.1% decrease - 2025-02-21 16:22:43
Vertex Pharmaceuticals (NASDAQ:VRTX) Lowered to Hold Rating by StockNews.com
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Wednesday. VRTX has been the subject of a number of other reports. Scotiabank raised their price objective on Vertex Pharmaceuticals from $433.00 to $450.00 and gave the stock […] - 2025-02-21 06:55:07
Are Wall Street Analysts Predicting Vertex Pharmaceuticals Stock Will Climb or Sink?
Vertex Pharmaceuticals has lagged behind the broader market over the past year, and Wall Street analysts are cautiously optimistic about the stock’s future. - 2025-02-20 14:51:41
Blue Trust Inc. Sells 2,077 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Blue Trust Inc. lowered its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 76.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 634 shares of the pharmaceutical company’s stock after selling 2,077 shares during the period. Blue […] - 2025-02-19 09:02:04
IUSG, ANET, VRTX, PH: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core S&P U.S. Growth ETF (Symbol: IUSG) where we have detected an approximate $324.0 million dollar outflow -- that's a 1.5% decrease we - 2025-02-13 15:47:21
Vertex Pharmaceuticals (NASDAQ:VRTX) Given “Hold” Rating at Needham & Company LLC
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “hold” rating restated by research analysts at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports. Other equities analysts have also issued reports about the stock. Citigroup started coverage on shares of Vertex Pharmaceuticals in a research report on Thursday, November 14th. […] - 2025-02-13 09:32:55
Vertex Pharmaceuticals (NASDAQ:VRTX) Given New $467.00 Price Target at Barclays
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target hoisted by analysts at Barclays from $435.00 to $467.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the pharmaceutical company’s stock. Barclays‘s price objective suggests a potential upside of 3.05% from […] - 2025-02-13 09:32:50
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $520.00
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective upped by equities researchers at Truist Financial from $460.00 to $520.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the pharmaceutical company’s stock. Truist Financial’s price target suggests a potential upside of 14.74% from the company’s […] - 2025-02-13 08:42:49
Fund Update: ALLIANCEBERNSTEIN L.P. Just Disclosed New Holdings
ALLIANCEBERNSTEIN L.P. just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-02-12 19:56:04
Vertex: Strong Sales, Stronger Pipeline
Here's our initial take on Vertex Pharmaceuticals' (NASDAQ: VRTX) fourth-quarter financial report.Key Metrics Metric Q4 2023 Q4 2024 Change vs. Expectations Revenue $2.52 billion $2.91 billion 16% Beat Earnings per share $3.71 $3.50 -6% Missed Trikafta/Kaftrio revenue $ - 2025-02-11 14:15:00
Fund Update: PARNASSUS INVESTMENTS, LLC Just Disclosed New Holdings
PARNASSUS INVESTMENTS, LLC just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-02-10 15:42:57
Earnings Season Scorecard and Analyst Reports for Meta Platforms, Mastercard & Adobe
A real-time update on the Q4 earnings season is included in today's Research Daily, in addition to featuring updated analyst reports on Meta Platforms (META), Mastercard (MA), Adobe (ADBE) and others. - 2025-02-04 17:49:00
Schwab U.S. Large-Cap Growth ETF Experiences Big Inflow
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab U.S. Large-Cap Growth ETF (Symbol: SCHG) where we have detected an approximate $315.4 million dollar inflow -- that's a 0.8% increase week ove - 2025-02-04 16:04:54
Stocks Retreat on Tariff Anxiety
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.14%. March E-mini S&P futures (ESH25 ) are down by -0.53%, and March E-mini Nasdaq... - 2025-02-03 14:54:37
Stocks Retreat on Tariff Anxiety
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.14%. March E-mini S&P futures (ESH25 ) are down by -0.53%, and March E-mini Nasdaq... - 2025-02-03 14:21:10
Stocks Retreat on Tariff Anxiety
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.14%. March E-mini S&P futures (ESH25 ) are down by -0.53%, and March E-mini Nasdaq... - 2025-02-03 12:52:57
Stocks Retreat on Tariff Anxiety
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.14%. March E-mini S&P futures (ESH25 ) are down by -0.53%, and March E-mini Nasdaq... - 2025-02-03 12:23:28
Scotiabank Issues Positive Forecast for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price hoisted by Scotiabank from $430.00 to $433.00 in a research note released on Friday morning,Benzinga reports. The brokerage currently has a sector perform rating on the pharmaceutical company’s stock. Several other research analysts have also issued reports on VRTX. Morgan Stanley upped their target price […] - 2025-02-03 07:01:06
Vertex Pharmaceuticals (NASDAQ:VRTX) Receives “Overweight” Rating from Cantor Fitzgerald
Cantor Fitzgerald restated their overweight rating on shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) in a research report released on Friday,Benzinga reports. Cantor Fitzgerald currently has a $480.00 price target on the pharmaceutical company’s stock. VRTX has been the topic of a number of other reports. Wells Fargo & Company cut shares of Vertex […] - 2025-02-03 07:01:05
HC Wainwright Forecasts Strong Price Appreciation for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price lifted by HC Wainwright from $535.00 to $550.00 in a research report sent to investors on Friday,Benzinga reports. HC Wainwright currently has a buy rating on the pharmaceutical company’s stock. A number of other analysts have also weighed in on VRTX. Citigroup began coverage on […] - 2025-02-03 07:01:05
Stocks Retreat on Tariff Anxiety
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.14%. March E-mini S&P futures (ESH25 ) are down by -0.53%, and March E-mini Nasdaq... - 2025-02-03 06:11:06
Should You Pick VRTX Stock At $450?
Vertex Pharmaceuticals stock (NASDAQ: VRTX) is trending higher after the U.S. FDA approved Journavx – an oral non-opioid pain medication. This is a big win for Vertex, given that Journavx can potentially garner $4 billion in annual peak sales. For perspective, Vertex’ - 2025-02-03 03:17:52
Stocks Retreat in Afternoon Trading
This afternoon, the S&P 500 Index ($SPX ) (SPY ) is down -0.48%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.71%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up -0.36%. Stocks are moving lower this afternoon, after the Dow Jones Industrials posted an... - 2025-02-01 00:40:50

iShares Edge MSCI World Minimum Volatility ESG UCITS ETF VRTX holdings

DateNumber of VRTX Shares HeldBase Market Value of VRTX SharesLocal Market Value of VRTX SharesChange in VRTX Shares HeldChange in VRTX Base ValueCurrent Price per VRTX Share HeldPrevious Price per VRTX Share Held
2025-03-11 (Tuesday)17,569USD 8,579,645VRTX holding decreased by -205031USD 8,579,6450USD -205,031 USD 488.34 USD 500.01
2025-03-10 (Monday)17,569VRTX holding increased by 171USD 8,784,676VRTX holding increased by 289407USD 8,784,676171USD 289,407 USD 500.01 USD 488.29
2025-03-07 (Friday)17,398VRTX holding increased by 684USD 8,495,269VRTX holding increased by 277998USD 8,495,269684USD 277,998 USD 488.29 USD 491.64
2025-03-05 (Wednesday)16,714USD 8,217,271VRTX holding increased by 90590USD 8,217,2710USD 90,590 USD 491.64 USD 486.22
2025-03-04 (Tuesday)16,714VRTX holding increased by 513USD 8,126,681VRTX holding increased by 296576USD 8,126,681513USD 296,576 USD 486.22 USD 483.31
2025-03-03 (Monday)16,201USD 7,830,105VRTX holding increased by 57027USD 7,830,1050USD 57,027 USD 483.31 USD 479.79
2025-02-28 (Friday)16,201VRTX holding increased by 77USD 7,773,078VRTX holding increased by 122240USD 7,773,07877USD 122,240 USD 479.79 USD 474.5
2025-02-27 (Thursday)16,124USD 7,650,838VRTX holding decreased by -74170USD 7,650,8380USD -74,170 USD 474.5 USD 479.1
2025-02-26 (Wednesday)16,124USD 7,725,008VRTX holding decreased by -20155USD 7,725,0080USD -20,155 USD 479.1 USD 480.35
2025-02-25 (Tuesday)16,124USD 7,745,163VRTX holding decreased by -20962USD 7,745,1630USD -20,962 USD 480.35 USD 481.65
2025-02-24 (Monday)16,124USD 7,766,125VRTX holding decreased by -41761USD 7,766,1250USD -41,761 USD 481.65 USD 484.24
2025-02-21 (Friday)16,124VRTX holding decreased by -170USD 7,807,886VRTX holding decreased by -18611USD 7,807,886-170USD -18,611 USD 484.24 USD 480.33
2025-02-20 (Thursday)16,294USD 7,826,497VRTX holding increased by 139640USD 7,826,4970USD 139,640 USD 480.33 USD 471.76
2025-02-19 (Wednesday)16,294USD 7,686,857VRTX holding increased by 157237USD 7,686,8570USD 157,237 USD 471.76 USD 462.11
2025-02-18 (Tuesday)16,294USD 7,529,620VRTX holding increased by 50674USD 7,529,6200USD 50,674 USD 462.11 USD 459
2025-02-17 (Monday)16,294USD 7,478,946USD 7,478,9460USD 0 USD 459 USD 459
2025-02-14 (Friday)16,294USD 7,478,946VRTX holding decreased by -58333USD 7,478,9460USD -58,333 USD 459 USD 462.58
2025-02-13 (Thursday)16,294USD 7,537,279VRTX holding increased by 152838USD 7,537,2790USD 152,838 USD 462.58 USD 453.2
2025-02-12 (Wednesday)16,294USD 7,384,441VRTX holding decreased by -32914USD 7,384,4410USD -32,914 USD 453.2 USD 455.22
2025-02-11 (Tuesday)16,294USD 7,417,355VRTX holding decreased by -240336USD 7,417,3550USD -240,336 USD 455.22 USD 469.97
2025-02-10 (Monday)16,294VRTX holding increased by 510USD 7,657,691VRTX holding increased by 249944USD 7,657,691510USD 249,944 USD 469.97 USD 469.32
2025-02-07 (Friday)15,784USD 7,407,747VRTX holding decreased by -186882USD 7,407,7470USD -186,882 USD 469.32 USD 481.16
2025-02-06 (Thursday)15,784USD 7,594,629VRTX holding decreased by -114908USD 7,594,6290USD -114,908 USD 481.16 USD 488.44
2025-02-05 (Wednesday)15,784USD 7,709,537VRTX holding increased by 97229USD 7,709,5370USD 97,229 USD 488.44 USD 482.28
2025-02-04 (Tuesday)15,784USD 7,612,308VRTX holding increased by 187988USD 7,612,3080USD 187,988 USD 482.28 USD 470.37
2025-02-03 (Monday)15,784USD 7,424,320VRTX holding increased by 137163USD 7,424,3200USD 137,163 USD 470.37 USD 461.68
2025-01-31 (Friday)15,784VRTX holding decreased by -79USD 7,287,157VRTX holding increased by 332818USD 7,287,157-79USD 332,818 USD 461.68 USD 438.4
2025-01-30 (Thursday)15,863USD 6,954,339VRTX holding decreased by -49493USD 6,954,3390USD -49,493 USD 438.4 USD 441.52
2025-01-29 (Wednesday)15,863USD 7,003,832VRTX holding increased by 13325USD 7,003,8320USD 13,325 USD 441.52 USD 440.68
2025-01-28 (Tuesday)15,863USD 6,990,507VRTX holding decreased by -50761USD 6,990,5070USD -50,761 USD 440.68 USD 443.88
2025-01-27 (Monday)15,863USD 7,041,268VRTX holding increased by 67576USD 7,041,2680USD 67,576 USD 443.88 USD 439.62
2025-01-24 (Friday)15,863USD 6,973,692VRTX holding decreased by -1745USD 6,973,6920USD -1,745 USD 439.62 USD 439.73
2025-01-23 (Thursday)15,863USD 6,975,437VRTX holding increased by 186073USD 6,975,4370USD 186,073 USD 439.73 USD 428
2025-01-22 (Wednesday)15,863USD 6,789,364USD 6,789,364
2025-01-21 (Tuesday)15,863USD 6,787,619USD 6,787,619
2025-01-20 (Monday)15,693USD 6,622,446USD 6,622,446
2025-01-17 (Friday)15,693USD 6,622,446USD 6,622,446
2025-01-16 (Thursday)15,693USD 6,543,353USD 6,543,353
2025-01-15 (Wednesday)15,693USD 6,657,912USD 6,657,912
2025-01-14 (Tuesday)15,693USD 6,460,180USD 6,460,180
2025-01-13 (Monday)15,693USD 6,487,015USD 6,487,015
2025-01-10 (Friday)15,693USD 6,427,225USD 6,427,225
2025-01-09 (Thursday)15,693USD 6,467,242USD 6,467,242
2025-01-09 (Thursday)15,693USD 6,467,242USD 6,467,242
2025-01-09 (Thursday)15,693USD 6,467,242USD 6,467,242
2025-01-08 (Wednesday)15,693USD 6,467,242USD 6,467,242
2025-01-08 (Wednesday)15,693USD 6,467,242USD 6,467,242
2025-01-08 (Wednesday)15,693USD 6,467,242USD 6,467,242
2025-01-02 (Thursday)15,863VRTX holding decreased by -1859USD 6,436,571VRTX holding decreased by -1878946USD 6,436,571-1,859USD -1,878,946 USD 405.76 USD 469.22
2024-12-31 (Tuesday)15,863USD 6,388,030USD 6,388,030
2024-12-30 (Monday)15,863USD 6,334,889USD 6,334,889
2024-12-27 (Friday)15,863USD 6,484,160USD 6,484,160
2024-12-26 (Thursday)15,863USD 6,514,141USD 6,514,141
2024-12-24 (Tuesday)15,863USD 6,474,959USD 6,474,959
2024-12-23 (Monday)15,863USD 6,428,798USD 6,428,798
2024-12-20 (Friday)15,863USD 6,301,894USD 6,301,894
2024-12-19 (Thursday)15,863USD 6,291,900USD 6,291,900
2024-12-18 (Wednesday)15,863USD 7,098,693USD 7,098,693
2024-12-17 (Tuesday)16,201USD 7,602,157USD 7,602,157
2024-12-16 (Monday)16,877USD 7,899,955USD 7,899,955
2024-12-13 (Friday)17,553USD 8,139,853USD 8,139,853
2024-12-11 (Wednesday)17,722USD 8,299,035USD 8,299,035
2024-12-10 (Tuesday)17,722USD 8,315,517VRTX holding decreased by -84357USD 8,315,5170USD -84,357 USD 469.22 USD 473.98
2024-12-09 (Monday)17,722VRTX holding decreased by -169USD 8,399,874VRTX holding increased by 132443USD 8,399,874-169USD 132,443 USD 473.98 USD 462.1
2024-12-06 (Friday)17,891USD 8,267,431VRTX holding increased by 39002USD 8,267,4310USD 39,002 USD 462.1 USD 459.92
2024-12-05 (Thursday)17,891USD 8,228,429VRTX holding decreased by -72637USD 8,228,4290USD -72,637 USD 459.92 USD 463.98
2024-12-04 (Wednesday)17,891USD 8,301,066VRTX holding increased by 125416USD 8,301,0660USD 125,416 USD 463.98 USD 456.97
2024-12-03 (Tuesday)17,891USD 8,175,650VRTX holding decreased by -156725USD 8,175,6500USD -156,725 USD 456.97 USD 465.73
2024-12-02 (Monday)17,891USD 8,332,375VRTX holding decreased by -42939USD 8,332,3750USD -42,939 USD 465.73 USD 468.13
2024-11-29 (Friday)17,891VRTX holding decreased by -199USD 8,375,314VRTX holding decreased by -28576USD 8,375,314-199USD -28,576 USD 468.13 USD 464.56
2024-11-28 (Thursday)18,090USD 8,403,890USD 8,403,8900USD 0 USD 464.56 USD 464.56
2024-11-27 (Wednesday)18,090USD 8,403,890VRTX holding decreased by -45406USD 8,403,8900USD -45,406 USD 464.56 USD 467.07
2024-11-26 (Tuesday)18,090USD 8,449,296VRTX holding increased by 96962USD 8,449,2960USD 96,962 USD 467.07 USD 461.71
2024-11-26 (Tuesday)18,090USD 8,449,296VRTX holding increased by 96962USD 8,449,2960USD 96,962 USD 467.07 USD 461.71
2024-11-25 (Monday)18,090VRTX holding decreased by -4029USD 8,352,334VRTX holding decreased by -1622671USD 8,352,334-4,029USD -1,622,671 USD 461.71 USD 450.97
2024-11-22 (Friday)22,119USD 9,975,005VRTX holding increased by 13271USD 9,975,0050USD 13,271 USD 450.97 USD 450.37
2024-11-21 (Thursday)22,119USD 9,961,734VRTX holding decreased by -19022USD 9,961,7340USD -19,022 USD 450.37 USD 451.23
2024-11-20 (Wednesday)22,119USD 9,980,756VRTX holding increased by 71223USD 9,980,7560USD 71,223 USD 451.23 USD 448.01
2024-11-19 (Tuesday)22,119VRTX holding decreased by -208USD 9,909,533VRTX holding decreased by -517399USD 9,909,533-208USD -517,399 USD 448.01 USD 467.01
2024-11-18 (Monday)22,327VRTX holding decreased by -416USD 10,426,932VRTX holding decreased by -717138USD 10,426,932-416USD -717,138 USD 467.01 USD 490
2024-11-12 (Tuesday)22,743VRTX holding decreased by -416USD 11,144,070VRTX holding decreased by -492170USD 11,144,070-416USD -492,170 USD 490 USD 502.45
2024-11-08 (Friday)23,159USD 11,967,182VRTX holding increased by 330942USD 11,967,1820USD 330,942 USD 516.74 USD 502.45
2024-11-07 (Thursday)23,159USD 11,636,240VRTX holding increased by 204031USD 11,636,2400USD 204,031 USD 502.45 USD 493.64
2024-11-06 (Wednesday)23,159USD 11,432,209VRTX holding decreased by -144512USD 11,432,2090USD -144,512 USD 493.64 USD 499.88
2024-11-05 (Tuesday)23,159USD 11,576,721VRTX holding increased by 627146USD 11,576,7210USD 627,146 USD 499.88 USD 472.8
2024-11-04 (Monday)23,159USD 10,949,575VRTX holding increased by 38907USD 10,949,5750USD 38,907 USD 472.8 USD 471.12
2024-11-01 (Friday)23,159USD 10,910,668VRTX holding decreased by -112553USD 10,910,6680USD -112,553 USD 471.12 USD 475.98
2024-10-31 (Thursday)23,159VRTX holding decreased by -87USD 11,023,221VRTX holding decreased by -20489USD 11,023,221-87USD -20,489 USD 475.98 USD 475.08
2024-10-30 (Wednesday)23,246USD 11,043,710VRTX holding increased by 109721USD 11,043,7100USD 109,721 USD 475.08 USD 470.36
2024-10-29 (Tuesday)23,246USD 10,933,989VRTX holding decreased by -170625USD 10,933,9890USD -170,625 USD 470.36 USD 477.7
2024-10-28 (Monday)23,246USD 11,073,697VRTX holding decreased by -30917USD 11,073,6970USD -30,917 USD 476.37 USD 477.7
2024-10-28 (Monday)23,246USD 11,073,697VRTX holding decreased by -30917USD 11,073,6970USD -30,917 USD 476.37 USD 477.7
2024-10-25 (Friday)23,246USD 11,104,614VRTX holding increased by 134594USD 11,104,6140USD 134,594 USD 477.7 USD 471.91
2024-10-24 (Thursday)23,246USD 10,970,020VRTX holding decreased by -257798USD 10,970,0200USD -257,798 USD 471.91 USD 483
2024-10-23 (Wednesday)23,246USD 10,926,782VRTX holding decreased by -112976USD 10,926,7820USD -112,976 USD 470.05 USD 474.91
2024-10-23 (Wednesday)23,246USD 10,926,782VRTX holding decreased by -112976USD 10,926,7820USD -112,976 USD 470.05 USD 474.91
2024-10-22 (Tuesday)23,246USD 11,039,758VRTX holding decreased by -73922USD 11,039,7580USD -73,922 USD 474.91 USD 478.09
2024-10-22 (Tuesday)23,246USD 11,039,758VRTX holding decreased by -73922USD 11,039,7580USD -73,922 USD 474.91 USD 478.09
2024-10-21 (Monday)23,246USD 11,113,680VRTX holding decreased by -114138USD 11,113,6800USD -114,138 USD 478.09 USD 483
2024-10-21 (Monday)23,246USD 11,113,680VRTX holding decreased by -114138USD 11,113,6800USD -114,138 USD 478.09 USD 483
2024-10-18 (Friday)23,246USD 11,227,818USD 11,227,818
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VRTX by Blackrock for IE00BKVL7778

Show aggregate share trades of VRTX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-03-10BUY171 500.010* 469.06
2025-03-07BUY684 488.290* 468.78
2025-03-04BUY513 486.220* 468.18
2025-02-28BUY77 479.790* 467.77
2025-02-21SELL-170 484.240* 466.75 Profit of 79,348 on sale
2025-02-10BUY510 469.970* 467.29
2025-01-31SELL-79 461.680* 466.19 Profit of 36,829 on sale
2025-01-02SELL-1,859 405.760* 471.82 Profit of 877,110 on sale
2024-12-09SELL-169 473.980* 471.83 Profit of 79,739 on sale
2024-11-29SELL-199 468.130* 473.64 Profit of 94,253 on sale
2024-11-25SELL-4,029 461.710* 475.36 Profit of 1,915,240 on sale
2024-11-19SELL-208 448.010* 480.17 Profit of 99,875 on sale
2024-11-18SELL-416 467.010* 480.83 Profit of 200,023 on sale
2024-11-12SELL-416 490.000* 480.34 Profit of 199,822 on sale
2024-10-31SELL-87 475.980* 474.49 Profit of 41,281 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VRTX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-03-12332,397653481,02169.1%
2025-03-11273,529437501,40954.6%
2025-03-10342,82352597,06757.4%
2025-03-07231,760226414,25555.9%
2025-03-06333,034102506,67265.7%
2025-03-05211,79523333,31363.5%
2025-03-04269,76434456,50559.1%
2025-03-03264,333109460,34757.4%
2025-02-28290,679561483,11260.2%
2025-02-27163,115716318,29751.2%
2025-02-26147,097945243,99860.3%
2025-02-25198,750113440,22045.1%
2025-02-24194,2909399,05648.7%
2025-02-21278,90716442,43663.0%
2025-02-20307,3420562,72954.6%
2025-02-19196,482807643,48430.5%
2025-02-18241,4326,621515,10946.9%
2025-02-14218,39658385,39856.7%
2025-02-13330,30769540,75161.1%
2025-02-12253,056586490,79051.6%
2025-02-11454,2461,902682,70666.5%
2025-02-10384,962106626,41361.5%
2025-02-07311,677511469,67766.4%
2025-02-06241,3734406,94159.3%
2025-02-05412,75666655,66563.0%
2025-02-04599,47243792,18975.7%
2025-02-03617,143398887,62269.5%
2025-01-311,191,3076371,734,41268.7%
2025-01-30261,23145462,12656.5%
2025-01-29207,10685460,01445.0%
2025-01-28300,3429430,70769.7%
2025-01-27345,21857512,56567.4%
2025-01-24400,74018682,55158.7%
2025-01-23488,926117635,94676.9%
2025-01-22209,467283402,08252.1%
2025-01-21359,6985,293550,66165.3%
2025-01-17347,33310536,60764.7%
2025-01-16323,363635500,29864.6%
2025-01-15285,9852,042463,10061.8%
2025-01-14273,399656557,39349.0%
2025-01-13344,521161709,60948.6%
2025-01-10404,383363670,27860.3%
2025-01-08230,17976441,78052.1%
2025-01-07259,653805673,98138.5%
2025-01-06257,038214745,81534.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.